Therefore, this secondary analysis of 4 randomized clinical trials investigated the association of MDMA with activation of oxytocin and vasopressin systems, the incidence and severity of MDMA-induced hyponatremia, and the possible role of fluid restriction in lowering the risk of hyponatremia. This evidence concerns the gene OXT and Hyponatremia.